538 related articles for article (PubMed ID: 25969338)
1. Inhibition of soluble epoxide hydrolase counteracts the development of renal dysfunction and progression of congestive heart failure in Ren-2 transgenic hypertensive rats with aorto-caval fistula.
Červenka L; Melenovský V; Husková Z; Škaroupková P; Nishiyama A; Sadowski J
Clin Exp Pharmacol Physiol; 2015 Jul; 42(7):795-807. PubMed ID: 25969338
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of soluble epoxide hydrolase does not improve the course of congestive heart failure and the development of renal dysfunction in rats with volume overload induced by aorto-caval fistula.
Červenka L; Melenovský V; Husková Z; Sporková A; Bürgelová M; Škaroupková P; Hwang SH; Hammock BD; Imig JD; Sadowski J
Physiol Res; 2015; 64(6):857-73. PubMed ID: 26047375
[TBL] [Abstract][Full Text] [Related]
3. Effect of angiotensin-converting enzyme blockade, alone or combined with blockade of soluble epoxide hydrolase, on the course of congestive heart failure and occurrence of renal dysfunction in Ren-2 transgenic hypertensive rats with aorto-caval fistula.
Kala P; Sedláková L; Škaroupková P; Kopkan L; Vaňourková Z; Táborský M; Nishiyama A; Hwang SH; Hammock BD; Sadowski J; Melenovský V; Imig JD; Červenka L
Physiol Res; 2018 Jul; 67(3):401-415. PubMed ID: 29527914
[TBL] [Abstract][Full Text] [Related]
4. Vasodilatory responses of renal interlobular arteries to epoxyeicosatrienoic acids analog are not enhanced in Ren-2 transgenic hypertensive rats: evidence against a role of direct vascular effects of epoxyeicosatrienoic acids in progression of experimental heart failure.
Sporková A; Husková Z; Škaroupková P; Rami Reddy N; Falck JR; Sadowski J; Červenka L
Physiol Res; 2017 Mar; 66(1):29-39. PubMed ID: 27782740
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of soluble epoxide hydrolase is renoprotective in 5/6 nephrectomized Ren-2 transgenic hypertensive rats.
Kujal P; Čertíková Chábová V; Škaroupková P; Husková Z; Vernerová Z; Kramer HJ; Walkowska A; Kompanowska-Jezierska E; Sadowski J; Kitada K; Nishiyama A; Hwang SH; Hammock BD; Imig JD; Červenka L
Clin Exp Pharmacol Physiol; 2014 Mar; 41(3):227-37. PubMed ID: 24471737
[TBL] [Abstract][Full Text] [Related]
6. Sex-linked differences in the mortality in Ren-2 transgenic hypertensive rats with aorto-caval fistula: effects of treatment with angiotensin converting enzyme alone and combined with inhibitor of soluble epoxide hydrolase.
Kala P; Červenka L; Škaroupková P; Táborský M; Kompanowska-Jezierska E; Sadowski J
Physiol Res; 2019 Aug; 68(4):589-601. PubMed ID: 31177795
[TBL] [Abstract][Full Text] [Related]
7. Different mechanisms of acute versus long-term antihypertensive effects of soluble epoxide hydrolase inhibition: studies in Cyp1a1-Ren-2 transgenic rats.
Sporková A; Jíchová S; Husková Z; Kopkan L; Nishiyama A; Hwang SH; Hammock BD; Imig JD; Kompanowska-Jezierska E; Sadowski J; Kramer HJ; Cervenka L
Clin Exp Pharmacol Physiol; 2014 Dec; 41(12):1003-13. PubMed ID: 25224811
[TBL] [Abstract][Full Text] [Related]
8. Combined Inhibition of Soluble Epoxide Hydrolase and Renin-Angiotensin System Exhibits Superior Renoprotection to Renin-Angiotensin System Blockade in 5/6 Nephrectomized Ren-2 Transgenic Hypertensive Rats with Established Chronic Kidney Disease.
Čertíková Chábová V; Kujal P; Škaroupková P; Varňourková Z; Vacková Š; Husková Z; Kikerlová S; Sadowski J; Kompanowska-Jezierska E; Baranowska I; Hwang SH; Hammock BD; Imig JD; Tesař V; Červenka L
Kidney Blood Press Res; 2018; 43(2):329-349. PubMed ID: 29529602
[TBL] [Abstract][Full Text] [Related]
9. Antihypertensive action of soluble epoxide hydrolase inhibition in Ren-2 transgenic rats is mediated by suppression of the intrarenal renin-angiotensin system.
Varcabova S; Huskova Z; Kramer HJ; Hwang SH; Hammock BD; Imig JD; Kitada K; Cervenka L
Clin Exp Pharmacol Physiol; 2013 Apr; 40(4):273-81. PubMed ID: 23039246
[TBL] [Abstract][Full Text] [Related]
10. Sex-linked differences in the course of chronic kidney disease and congestive heart failure: a study in 5/6 nephrectomized Ren-2 transgenic hypertensive rats with volume overload induced using aorto-caval fistula.
Červenka L; Škaroupková P; Kompanowska-Jezierska E; Sadowski J
Clin Exp Pharmacol Physiol; 2016 Oct; 43(10):883-95. PubMed ID: 27385471
[TBL] [Abstract][Full Text] [Related]
11. Altered Renal Vascular Responsiveness to Vasoactive Agents in Rats with Angiotensin II-Dependent Hypertension and Congestive Heart Failure.
Vacková Š; Kikerlová S; Melenovsky V; Kolář F; Imig JD; Kompanowska-Jezierska E; Sadowski J; Červenka L
Kidney Blood Press Res; 2019; 44(4):792-809. PubMed ID: 31430751
[TBL] [Abstract][Full Text] [Related]
12. Antihypertensive and renoprotective actions of soluble epoxide hydrolase inhibition in ANG II-dependent malignant hypertension are abolished by pretreatment with L-NAME.
Honetschlägerová Z; Kitada K; Husková Z; Sporková A; Kopkan L; Bürgelová M; Varcabová Š; Nishiyama A; Hwang SH; Hammock BD; Imig JD; Kramer HJ; Kujal P; Vernerová Z; Červenka L
J Hypertens; 2013 Feb; 31(2):321-32. PubMed ID: 23307303
[TBL] [Abstract][Full Text] [Related]
13. Intrarenal alterations of the angiotensin-converting enzyme type 2/angiotensin 1-7 complex of the renin-angiotensin system do not alter the course of malignant hypertension in Cyp1a1-Ren-2 transgenic rats.
Husková Z; Kopkan L; Červenková L; Doleželová Š; Vaňourková Z; Škaroupková P; Nishiyama A; Kompanowska-Jezierska E; Sadowski J; Kramer HJ; Červenka L
Clin Exp Pharmacol Physiol; 2016 Apr; 43(4):438-49. PubMed ID: 26833491
[TBL] [Abstract][Full Text] [Related]
14. Renal mechanisms contributing to the antihypertensive action of soluble epoxide hydrolase inhibition in Ren-2 transgenic rats with inducible hypertension.
Honetschlägerová Z; Husková Z; Vaňourková Z; Sporková A; Kramer HJ; Hwang SH; Tsai HJ; Hammock BD; Imig JD; Červenka L; Kopkan L
J Physiol; 2011 Jan; 589(Pt 1):207-19. PubMed ID: 21078594
[TBL] [Abstract][Full Text] [Related]
15. Addition of Endothelin A-Receptor Blockade Spoils the Beneficial Effect of Combined Renin-Angiotensin and Soluble Epoxide Hydrolase Inhibition: Studies on the Course of Chronic Kidney Disease in 5/6 Nephrectomized Ren-2 Transgenic Hypertensive Rats.
Čertíková Chábová V; Kujal P; Vaňourková Z; Škaroupková P; Sadowski J; Kompanowska-Jezierska E; Tesař V; Hammock B; Imig J; Maxová H; Červenka L; Vaněčková I
Kidney Blood Press Res; 2019; 44(6):1493-1505. PubMed ID: 31770762
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of soluble epoxide hydrolase by cis-4-[4-(3-adamantan-1-ylureido)cyclohexyl-oxy]benzoic acid exhibits antihypertensive and cardioprotective actions in transgenic rats with angiotensin II-dependent hypertension.
Neckář J; Kopkan L; Husková Z; Kolář F; Papoušek F; Kramer HJ; Hwang SH; Hammock BD; Imig JD; Malý J; Netuka I; Ošťádal B; Červenka L
Clin Sci (Lond); 2012 Jun; 122(11):513-25. PubMed ID: 22324471
[TBL] [Abstract][Full Text] [Related]
17. Renal Sympathetic Denervation Attenuates Congestive Heart Failure in Angiotensin II-Dependent Hypertension: Studies with Ren-2 Transgenic Hypertensive Rats with Aortocaval Fistula.
Honetschlagerová Z; Gawrys O; Jíchová Š; Škaroupková P; Kikerlová S; Vaňourková Z; Husková Z; Melenovský V; Kompanowska-Jezierska E; Sadowski J; Kolář F; Novotný J; Hejnová L; Kujal P; Červenka L
Kidney Blood Press Res; 2021; 46(1):95-113. PubMed ID: 33530085
[TBL] [Abstract][Full Text] [Related]
18. Endothelin type A receptor blockade attenuates aorto-caval fistula-induced heart failure in rats with angiotensin II-dependent hypertension.
Kala P; Gawrys O; Miklovič M; Vaňourková Z; Škaroupková P; Jíchová Š; Sadowski J; Kompanowska-Jezierska E; Walkowska A; Veselka J; Táborský M; Maxová H; Vaněčková I; Červenka L
J Hypertens; 2023 Jan; 41(1):99-114. PubMed ID: 36204993
[TBL] [Abstract][Full Text] [Related]
19. Meloxicam fails to augment the reno-protective effects of soluble epoxide hydrolase inhibition in streptozotocin-induced diabetic rats via increased 20-HETE levels.
Katary MM; Pye C; Elmarakby AA
Prostaglandins Other Lipid Mediat; 2017 Sep; 132():3-11. PubMed ID: 27596333
[TBL] [Abstract][Full Text] [Related]
20. Effects of Epoxyeicosatrienoic Acid-Enhancing Therapy on the Course of Congestive Heart Failure in Angiotensin II-Dependent Rat Hypertension: From mRNA Analysis towards Functional In Vivo Evaluation.
Kala P; Miklovič M; Jíchová Š; Škaroupková P; Vaňourková Z; Maxová H; Gawrys O; Kompanowska-Jezierska E; Sadowski J; Imig JD; Falck JR; Veselka J; Červenka L; Aiglová R; Vícha M; Gloger V; Táborský M
Biomedicines; 2021 Aug; 9(8):. PubMed ID: 34440257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
